News from us and our partners

Tags

Topics

0 results

News
18 March, 2025
Forth Tx launches with backing from Sofinnova Partners to revolutionize fibrosis treatments
News
18 March, 2025
BioClec launches with backing from Sofinnova Partners to pioneer breakthrough Alzheimer’s Therapies
News
18 March, 2025
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
News
18 March, 2025
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
News
12 March, 2025
Purespring Therapeutics appoints Haseeb Ahmad as Chief Executive Officer
News
10 March, 2025
May Health appoints seasoned medtech executive, Colby Holtshouse, as President and CEO
News
10 March, 2025
T-Therapeutics appoints Theodora Harold as Chief Executive Officer, reflecting Company’s ambitious growth plans and progression into therapeutic development
News
4 March, 2025
Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
News
3 March, 2025
Pi-Cardia Reports First Commercial Cases with ShortCut™
Feature
28 February, 2025
Healthcare in the post-COVID era, where is Cell and Gene Therapy going?
News
26 February, 2025
NanoPhoria Bioscience awarded €17.5 M from European Innovation Council’s accelerator program
News
25 February, 2025
TISSIUM strengthens executive leadership team with key appointments
News
13 February, 2025
Latent Labs secures $50M in funding to realize the potential of AI-powered, programmable biology
News
10 February, 2025
RefleXion expands access to SCINTIX therapy with first freestanding cancer center
News
31 January, 2025
BrightHeart unveils breakthrough AI results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, revolutionizing prenatal care
News
20 January, 2025
Amid the buzz at JP Morgan conference, Sofinnova Partners' Antoine Papiernik is optimistic

Forth Tx launches with backing from Sofinnova Partners to revolutionize fibrosis treatments

BioClec launches with backing from Sofinnova Partners to pioneer breakthrough Alzheimer’s Therapies

Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support

Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership

Purespring Therapeutics appoints Haseeb Ahmad as Chief Executive Officer

May Health appoints seasoned medtech executive, Colby Holtshouse, as President and CEO

T-Therapeutics appoints Theodora Harold as Chief Executive Officer, reflecting Company’s ambitious growth plans and progression into therapeutic development

Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation

Pi-Cardia Reports First Commercial Cases with ShortCut™

Healthcare in the post-COVID era, where is Cell and Gene Therapy going?

NanoPhoria Bioscience awarded €17.5 M from European Innovation Council’s accelerator program

TISSIUM strengthens executive leadership team with key appointments

Latent Labs secures $50M in funding to realize the potential of AI-powered, programmable biology

RefleXion expands access to SCINTIX therapy with first freestanding cancer center

BrightHeart unveils breakthrough AI results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, revolutionizing prenatal care

Amid the buzz at JP Morgan conference, Sofinnova Partners' Antoine Papiernik is optimistic